EMBECTA CORP. Impairment of Long-Lived Assets Held-for-use
EMBECTA CORP. (EMBC) reported Impairment of Long-Lived Assets Held-for-use of $0 for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfLongLivedAssetsHeldForUse · last filed 2022-08-15
- EMBECTA CORP. impairment of long-lived assets held-for-use for the quarter ending 2022-06-30 was $0.00, a 100.00% decline year-over-year.
- EMBECTA CORP. impairment of long-lived assets held-for-use for the quarter ending 2022-03-31 was $0.00.
- EMBECTA CORP. impairment of long-lived assets held-for-use for the quarter ending 2021-06-30 was $3.80M.
| Period end | Impairment of Long-Lived Assets Held-for-use 3 month | Impairment of Long-Lived Assets Held-for-use 6 month | Impairment of Long-Lived Assets Held-for-use 9 month |
|---|---|---|---|
| 2022-06-30 | $0.00 10-Q · filed 2022-08-15 | $0.00 derived: sum of 2 quarters · filed 2022-08-15 | $0.00 10-Q · filed 2022-08-15 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-13 | $0.00 10-Q · filed 2022-05-13 | |
| 2021-06-30 | $3.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-15 | $13.80M 10-Q · filed 2022-08-15 | |
| 2021-03-31 | $10.00M 10-Q · filed 2022-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |